Caribou Biosciences Inc.
CRBU | NASDAQ
$1.33
+$0.03 (+2.31%)
Sep 22, 2026, 1:14 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -24.28M | -25.09M | -26.49M | -27.55M | -54.1M | -39.99M | -35.49M | -34.68M | -37.7M | -41.23M | -34.51M | -10M | -29.52M | -28.04M | -26.99M | -26.65M | -26.7M | -19.09M | -18.48M | -20.97M | -14.31M | -13.16M |
Depreciation & Amortization | 625K | 649K | 682K | 631K | 1.17M | 1.17M | 1.18M | 1.18M | 856K | 710K | 740K | 1.58M | 617K | 589K | 506K | 450K | 358K | 308K | 273K | 260K | 230K | 221K |
Stock-Based Compensation | 2.48M | 2.36M | 2.74M | 2.93M | 3.13M | 3.88M | 3.91M | 4.07M | 4.74M | 3.99M | 3.56M | 3.48M | 3.59M | 3.13M | 3.1M | 2.67M | 2.92M | 3.02M | 1.58M | 935K | 593K | 343K |
Other Working Capital | -1.49M | -3.35M | -3K | -1.82M | 1.22M | -3.41M | -3.49M | -2.6M | 4.53M | -3.81M | 3.02M | -19.72M | 10.45M | -3.69M | -307K | -2.41M | 3.06M | -5.28M | -2.93M | 1.97M | -1.31M | 32.84M |
Other Non-Cash Items | 277K | 46K | 377K | 210K | 20.99M | -285K | -773K | -399K | -3.62M | 182K | 3.81M | -1.77M | -1.96M | -1.25M | -1.53M | 1.86M | -191K | -809K | -2.11M | 2.4M | -87K | 693K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 321K | n/a | n/a | n/a |
Change in Working Capital | -1.88M | -4.95M | 1.87M | -1.41M | 554K | -1.5M | -4.3M | -2.82M | 2.86M | -849K | 5.02M | -22.07M | 12.09M | -2.36M | -128K | -707K | 1.74M | -5.11M | -2.98M | 2.41M | -2.9M | 32.22M |
Operating Cash Flow | -22.79M | -26.98M | -20.82M | -25.19M | -28.26M | -36.73M | -35.47M | -32.66M | -32.87M | -37.2M | -21.38M | -28.79M | -15.19M | -27.94M | -25.04M | -22.38M | -21.87M | -21.67M | -21.39M | -14.97M | -16.48M | 20.31M |
Capital Expenditures | -1K | -72K | 216K | -115K | -418K | -1.04M | -518K | -673K | -2.37M | -2.95M | -2.28M | -4.75M | -2.55M | -2.03M | -2.06M | -1.65M | -2.62M | -723K | -685K | -930K | -484K | -22K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -20.5M | -22.35M | -44.03M | -57.45M | -32.22M | -15.53M | -55.5M | -93.47M | -84.24M | -71.18M | -84.19M | -175.89M | -58.74M | -75.93M | -86.51M | -70.81M | -71.06M | -110.68M | -173.28M | n/a | n/a | n/a |
Sales Maturities Of Investments | 39.45M | 46.14M | 61.79M | 68.41M | 56.67M | 65.96M | 71.94M | 120.66M | 107.8M | 97.09M | 55M | 112.17M | 72.36M | 98.67M | 89.74M | 64.12M | 59.71M | 39.3M | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | 269K | n/a | n/a | n/a | n/a | -1.61M | 1.63M | -125K | -1.5M | n/a | n/a | n/a | n/a | -300K | -300K | n/a | n/a | n/a | -1M | n/a | n/a |
Investing Cash Flow | 18.94M | 23.99M | 17.97M | 10.85M | 24.04M | 49.38M | 15.93M | 26.52M | 21.2M | 22.96M | -31.47M | -68.48M | 11.06M | 20.7M | 1.17M | -8.34M | -13.97M | -72.11M | -173.96M | -1.93M | -484K | -22K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.15M | -119K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | -462K | n/a | 913K | n/a | -537K | 1.16M | 70K | 753K | 236K | 519K | 127K | 654K | 362K | n/a | n/a | n/a | n/a | 564K |
Financial Cash Flow | 17.94M | 2.7M | 4.07M | 277K | 6K | 468K | 3.86M | 244K | 132K | 12.49M | -43K | 135.13M | 17.57M | 1.64M | 127K | 654K | 362K | 990K | 460K | 322.68M | 606K | 109.68M |
Net Cash Flow | 14.09M | -303K | 1.22M | -14.06M | -4.22M | 13.12M | -15.68M | -5.9M | -11.53M | -1.76M | -52.9M | 37.86M | 13.45M | -5.59M | -23.75M | -30.06M | -35.48M | -92.79M | -194.89M | 305.79M | -16.4M | 129.97M |
Free Cash Flow | -22.79M | -27.06M | -20.61M | -25.3M | -28.68M | -37.77M | -35.99M | -33.33M | -35.23M | -40.15M | -23.66M | -33.54M | -17.74M | -29.97M | -27.1M | -24.03M | -24.49M | -22.4M | -22.07M | -15.9M | -16.96M | 20.29M |
Adj. Free Cash Flow | -25.27M | -29.41M | -23.35M | -28.23M | -31.81M | -41.65M | -39.9M | -37.4M | -39.97M | -44.14M | -27.21M | -37.02M | -21.32M | -33.1M | -30.2M | -26.7M | -27.41M | -25.42M | -23.65M | -16.83M | -17.55M | 19.95M |
Maintenance CapEx | -1K | -72K | 432K | n/a | -418K | -1.04M | -518K | -673K | -2.37M | -2.95M | -2.28M | n/a | -2.55M | -1.06M | -759.74K | -1.65M | n/a | n/a | n/a | n/a | -484K | -22K |
Growth CapEx | n/a | n/a | -216K | -115K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.75M | n/a | -970.25K | -1.3M | n/a | -2.62M | -723K | -685K | -930K | n/a | n/a |
Owner Earnings | -22.79M | -27.06M | -20.39M | -25.19M | -28.68M | -37.77M | -35.99M | -33.33M | -35.23M | -40.15M | -23.66M | -28.79M | -17.74M | -29M | -25.8M | -24.03M | -21.87M | -21.67M | -21.39M | -14.97M | -16.96M | 20.29M |
Add to Watchlist
Select watchlists to add or remove CRBU